PRINCETON, New Jersey, May 22, 2018 /PRNewswire/ -- WCG™ (WIRB-Copernicus Group®) Clinical Services Division, the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the opening of the company's new office in Tokyo, Japan. WCG's expanded presence in the Asia-Pacific region will strengthen its ability to support increasingly complex, global clinical trials, particularly in the critical areas of drug and diagnostic development for oncology and central nervous system (CNS) diseases.
WCG maintains an active presence in 65 countries around the world, helping research sponsors, contract research organizations (CROs) and investigative sites to work together more effectively to conduct faster, safer, and more predictable clinical trials.
In the past decade, Asia has become an increasingly attractive destination for clinical research, with a clinical trials infrastructure designed to foster speed, cost effectiveness and quality. With a population of more than four billion people, Asia also provides research sponsors with access to a large number of patients for clinical trial recruitment.
WCG (WIRB-Copernicus Group) is the world's leading provider of solutions that measurably improve the quality and efficiency of clinical research. The industry's first clinical services organization (CSO), WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human subject protections. For more information, please visit www.wcgclinical.com or follow us on Twitter @WCGClinical.
CONTACT: Media Contact: Lisa S. Osborne, Rana Healthcare Solutions, 206.992.5245, email@example.com ; WCG Contact: Craig Sowell, Chief Marketing Officer, 609.945.0109, firstname.lastname@example.org